PAMELA SMITH: Open Payments
NPI 1588655666 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$637 in 31 payments from 11 companies in 2025. Trend: 2023 $789 · 2024 $1,649 · 2025 $637
Food & beverage: $637
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 8 | $149 |
| Vanda Pharmaceuticals Inc. | 4 | $107 |
| ABBVIE INC. | 4 | $74 |
| Indivior Inc. | 3 | $66 |
| Neurocrine BioSciences, Inc. | 2 | $53 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $42 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Tris Pharma Inc | 1 | $18 |
Products named: ARISTADA, HETLIOZ, VRAYLAR, SUBLOCADE, INGREZZA, UZEDY, VIVITROL, COBENFY.
Industry payments across NC — which companies pay providers there.
